Skip to main content
Top
Published in: The Cerebellum 4/2020

Open Access 01-08-2020 | Paraneoplastic Cerebellar Degeneration | Consensus paper

Diagnostic Criteria for Primary Autoimmune Cerebellar Ataxia—Guidelines from an International Task Force on Immune-Mediated Cerebellar Ataxias

Authors: Marios Hadjivassiliou, Francesc Graus, Jerome Honnorat, Sven Jarius, Maarten Titulaer, Mario Manto, Nigel Hoggard, Ptolemaios Sarrigiannis, Hiroshi Mitoma

Published in: The Cerebellum | Issue 4/2020

Login to get access

Abstract

Aside from well-characterized immune-mediated ataxias with a clear trigger and/or association with specific neuronal antibodies, a large number of idiopathic ataxias are suspected to be immune mediated but remain undiagnosed due to lack of diagnostic biomarkers. Primary autoimmune cerebellar ataxia (PACA) is the term used to describe this later group. An International Task Force comprising experts in the field of immune ataxias was commissioned by the Society for Research on the Cerebellum and Ataxias (SRCA) in order to devise diagnostic criteria aiming to improve the diagnosis of PACA. The proposed diagnostic criteria for PACA are based on clinical (mode of onset, pattern of cerebellar involvement, presence of other autoimmune diseases), imaging findings (MRI and if available MR spectroscopy showing preferential, but not exclusive involvement of vermis) and laboratory investigations (CSF pleocytosis and/or CSF-restricted IgG oligoclonal bands) parameters. The aim is to enable clinicians to consider PACA when encountering a patient with progressive ataxia and no other diagnosis given that such consideration might have important therapeutic implications.
Literature
1.
go back to reference Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75:1135–40.CrossRef Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75:1135–40.CrossRef
2.
go back to reference Hadjivassiliou M, Grünewald RA, Chattopadhyay AK, Davies-Jones GA, Gibson A, Jarratt JA, et al. Clinical, radiological, neurophysiological and neuropathological characteristics of gluten ataxia. Lancet. 1998;352:1582–5.CrossRef Hadjivassiliou M, Grünewald RA, Chattopadhyay AK, Davies-Jones GA, Gibson A, Jarratt JA, et al. Clinical, radiological, neurophysiological and neuropathological characteristics of gluten ataxia. Lancet. 1998;352:1582–5.CrossRef
3.
go back to reference Hadjivassiliou M, Zis P. Post-infectious immune mediated neurological diseases. In: Neuroimmune diseases; from cells to the living brain. Ed. M Manto, H Mitoma, Springer 2019. Hadjivassiliou M, Zis P. Post-infectious immune mediated neurological diseases. In: Neuroimmune diseases; from cells to the living brain. Ed. M Manto, H Mitoma, Springer 2019.
4.
go back to reference Hadjivassiliou M. Primary autoimmune cerebellar Ataxia (PACA). Adv Clin Neurosci Rehabil. 2010;9:8–11. Hadjivassiliou M. Primary autoimmune cerebellar Ataxia (PACA). Adv Clin Neurosci Rehabil. 2010;9:8–11.
6.
go back to reference Grimaldi S, Boucekine M, Witjas T, Fluchère F, Renaud M, Azulay JP, et al. Multiple system atrophy: phenotypic spectrum approach coupled with brain 18-FDG PET. Parkinsonism Relat Disord. 2019;67:3–9.CrossRef Grimaldi S, Boucekine M, Witjas T, Fluchère F, Renaud M, Azulay JP, et al. Multiple system atrophy: phenotypic spectrum approach coupled with brain 18-FDG PET. Parkinsonism Relat Disord. 2019;67:3–9.CrossRef
7.
go back to reference Hadjivassiliou M, Boscolo S, Tongiorgi E, et al. Cerebellar ataxia as a possible organ specific autoimmune disease. Mov Disord. 2008;23(10):1270–377.CrossRef Hadjivassiliou M, Boscolo S, Tongiorgi E, et al. Cerebellar ataxia as a possible organ specific autoimmune disease. Mov Disord. 2008;23(10):1270–377.CrossRef
8.
go back to reference Jarius S, Wildemann B. ‘Medusa head ataxia’: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfall, summary and outlook. J Neuroinflammation. 2015;1712:168.CrossRef Jarius S, Wildemann B. ‘Medusa head ataxia’: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfall, summary and outlook. J Neuroinflammation. 2015;1712:168.CrossRef
9.
go back to reference Mitoma H, Adhikari K, Aeschlimann D, et al. Consensus paper: neuroimmune mechanisms of cerebellar ataxias. Cerebellum. 2016;15:2313–32.CrossRef Mitoma H, Adhikari K, Aeschlimann D, et al. Consensus paper: neuroimmune mechanisms of cerebellar ataxias. Cerebellum. 2016;15:2313–32.CrossRef
11.
go back to reference Hadjivassiliou M, Grunewald RA, Sanders DS, Shanmugarajah P, Hoggard N. Effect of gluten-free diet on MR spectroscopy in gluten ataxia. Neurology. 2017;89:1–5.CrossRef Hadjivassiliou M, Grunewald RA, Sanders DS, Shanmugarajah P, Hoggard N. Effect of gluten-free diet on MR spectroscopy in gluten ataxia. Neurology. 2017;89:1–5.CrossRef
12.
go back to reference Hadjivassiliou M, Currie S, Hoggard N. MR spectroscopy in paraneoplastic cerebellar degeneration. J Neuroradiol. 2013;40(4):3310.CrossRef Hadjivassiliou M, Currie S, Hoggard N. MR spectroscopy in paraneoplastic cerebellar degeneration. J Neuroradiol. 2013;40(4):3310.CrossRef
14.
go back to reference Blackburn DJ, Forbes M, Unwin Z, Hoggard N, Hadjivassiliou M, Sarrigiannis PG. Exaggerated startle in post-infectious opsoclonus myoclonus syndrome. Clin Neurophysiol. 2018;129:1372–3.CrossRef Blackburn DJ, Forbes M, Unwin Z, Hoggard N, Hadjivassiliou M, Sarrigiannis PG. Exaggerated startle in post-infectious opsoclonus myoclonus syndrome. Clin Neurophysiol. 2018;129:1372–3.CrossRef
15.
go back to reference Storstein A, Krossnes BK, Vedeler CA. Morphological and immunohostochemical characterization of paraneoplastic cerebellar degeneration associated with Yo antibodies. Acta Neurol Scand. 2009;120:64–7.CrossRef Storstein A, Krossnes BK, Vedeler CA. Morphological and immunohostochemical characterization of paraneoplastic cerebellar degeneration associated with Yo antibodies. Acta Neurol Scand. 2009;120:64–7.CrossRef
18.
go back to reference Jones AL, Flanagan EP, Pittock SJ, Mandrekar JN, Eggers SD, Ahlskog JE, et al. Responses to and outcomes of treatment of autoimmune cerebellar ataxia in adults. JAMA Neurol. 2015;72:1304–12.CrossRef Jones AL, Flanagan EP, Pittock SJ, Mandrekar JN, Eggers SD, Ahlskog JE, et al. Responses to and outcomes of treatment of autoimmune cerebellar ataxia in adults. JAMA Neurol. 2015;72:1304–12.CrossRef
Metadata
Title
Diagnostic Criteria for Primary Autoimmune Cerebellar Ataxia—Guidelines from an International Task Force on Immune-Mediated Cerebellar Ataxias
Authors
Marios Hadjivassiliou
Francesc Graus
Jerome Honnorat
Sven Jarius
Maarten Titulaer
Mario Manto
Nigel Hoggard
Ptolemaios Sarrigiannis
Hiroshi Mitoma
Publication date
01-08-2020
Publisher
Springer US
Published in
The Cerebellum / Issue 4/2020
Print ISSN: 1473-4222
Electronic ISSN: 1473-4230
DOI
https://doi.org/10.1007/s12311-020-01132-8

Other articles of this Issue 4/2020

The Cerebellum 4/2020 Go to the issue